Related references
Note: Only part of the references are listed.Development and validation of a circulating microRNA panel for the early detection of breast cancer
Ruiyang Zou et al.
BRITISH JOURNAL OF CANCER (2022)
Small non-coding RNA profiling in breast cancer: plasma U6 snRNA, miR-451a and miR-548b-5p as novel diagnostic and prognostic biomarkers
Ludek Zavesky et al.
MOLECULAR BIOLOGY REPORTS (2022)
Circulating microRNA-103a-3p could be a diagnostic and prognostic biomarker for breast cancer
Hui Liu et al.
ONCOLOGY LETTERS (2022)
Evaluation of Expressed MicroRNAs as Prospective Biomarkers for Detection of Breast Cancer
Amal Ahmed Mohamed et al.
DIAGNOSTICS (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Circulating status of microRNAs 660-5p and 210-3p in breast cancer patients
Zahra Nashtahosseini et al.
JOURNAL OF GENE MEDICINE (2021)
Breast cancer
Sibylle Loibl et al.
LANCET (2021)
Identification of miR-25-3p as a tumor biomarker: Regulation of cellular functions via TOB1 in breast cancer
Tianyi Zhao et al.
MOLECULAR MEDICINE REPORTS (2021)
A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer
Maha M. Itani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer
Kai Zhang et al.
PATHOLOGY RESEARCH AND PRACTICE (2021)
Impact of circulating miRNA-373 on breast cancer diagnosis through targeting VEGF and cyclin D1 genes
Noha M. Bakr et al.
JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2021)
Early detection breast cancer: role of circulating plasma miRNA-21 expression as a potential screening biomarker
Muhammad Noor Diansyah et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2021)
Multiple microRNAs as biomarkers for early breast cancer diagnosis
Ji Young Jang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2021)
Ribonucleic-acid-biomarker candidates for early-phase group detection of common cancers
Elmira Shajari et al.
GENOMICS (2020)
Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer- A Comparison
Vahid Arabkari et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types
Belen Pastor-Navarro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea
Jungho Kim et al.
MEDICINA-LITHUANIA (2020)
Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study
Veronika Holubekova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Candidate circulating microRNAs as potential diagnostic and predictive biomarkers for the monitoring of locally advanced breast cancer patients
Alaa M Ibrahim et al.
TUMOR BIOLOGY (2020)
Combination of circulating miR-145-5p/miR-191-5p as biomarker for breast cancer detection
Yeldar Ashirbekov et al.
PEERJ (2020)
Circulatory miRNA-155, miRNA-21 target PTEN expression and activity as a factor in breast cancer development
Saman Abdulrahman Ali et al.
CELLULAR AND MOLECULAR BIOLOGY (2020)
Plasma miR-1273g-3p acts as a potential biomarker for early Breast Ductal Cancer diagnosis
Huan Guo et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2020)
Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
Peter McAnena et al.
BMC CANCER (2019)
Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer
Maria Isabel Pena-Cano et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2019)
The diagnostic power of circulating micro ribonucleic acid 34a in combination with cancer antigen 15-3 as a potential biomarker of breast cancer
Anmar R. Raheem et al.
SAUDI MEDICAL JOURNAL (2019)
Circulating miR-21 and miR-155 as potential noninvasive biomarkers in Iranian Azeri patients with breast carcinoma
Elaheh Soleimanpour et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer
Nadia Heydari et al.
GENE (2018)
Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA
Martin Zaleski et al.
Oncotarget (2018)
MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
Mustafa Kahraman et al.
SCIENTIFIC REPORTS (2018)
Overview of the Process of Conducting Meta-analyses of the Diagnostic Test Accuracy
Young Ho Lee
JOURNAL OF RHEUMATIC DISEASES (2018)
Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling
Kai Zhang et al.
GENE (2017)
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
Rimi Hamam et al.
CELL DEATH & DISEASE (2017)
MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer
Song Gao et al.
ONCOTARGET (2017)
Recommendations for reporting of systematic reviews and meta-analyses of diagnostic test accuracy: a systematic review
Trevor A. McGrath et al.
SYSTEMATIC REVIEWS (2017)
Circulating microRNA-based screening tool for breast cancer
Pierre Freres et al.
ONCOTARGET (2016)
Novel combination of serum microRNA for detecting breast cancer in the early stage
Akihiko Shimomura et al.
CANCER SCIENCE (2016)
Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women
Tarek Mohamed Kamal Motawi et al.
GENE (2016)
Serum expression levels of microRNA-382-3p,-598-3p,-1246 and-184 in breast cancer patients
Lun Fu et al.
ONCOLOGY LETTERS (2016)
Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer
Seema Thakur et al.
PLOS ONE (2016)
microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection
Rimi Hamam et al.
SCIENTIFIC REPORTS (2016)
Plasma exosome microRNAs are indicative of breast cancer
Bethany N. Hannafon et al.
BREAST CANCER RESEARCH (2016)
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
Silvia Antolin et al.
BMC CANCER (2015)
A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer
Lei Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Tumor MicroRNA Expression Profiling Identifies Circulating MicroRNAs for Early Breast Cancer Detection
Nerea Matamala et al.
CLINICAL CHEMISTRY (2015)
Role of microRNAs-29b-2,-155,-197 and-205 as diagnostic biomarkers in serum of breast cancer females
Olfat Shaker et al.
GENE (2015)
Reduced expression levels of let-7c in human breast cancer patients
Xin-Xin Li et al.
ONCOLOGY LETTERS (2015)
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR
Alessandra Mangolini et al.
BIOMARKER RESEARCH (2015)
MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers
Silvia Zearo et al.
BMC CANCER (2014)
Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
Marek Sochor et al.
BMC CANCER (2014)
Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases
S. A. Joosse et al.
BRITISH JOURNAL OF CANCER (2014)
Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer
Fu-long Zhao et al.
MOLECULAR BIOLOGY REPORTS (2014)
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study
Annette R. Kodahl et al.
MOLECULAR ONCOLOGY (2014)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
Ailbhe M. McDermott et al.
PLOS ONE (2014)
Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
Jie Shen et al.
ONCOTARGET (2014)
Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
Corinna Eichelser et al.
ONCOTARGET (2014)
miRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer
Khouloud Hamdi et al.
SPRINGERPLUS (2014)
Identification of Circulating MicroRNA Signatures for Breast Cancer Detection
Maurice Chan et al.
CLINICAL CANCER RESEARCH (2013)
Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
Corinna Eichelser et al.
CLINICAL CHEMISTRY (2013)
Circulating microRNAs in plasma as early detection markers for breast cancer
Katarina Cuk et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer
Haiyan Si et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Effects of Polycystic Ovary Syndrome (PCOS), Sex Hormones, and Obesity on Circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 Expression
Mora Murri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer
Rui-chao Zeng et al.
MEDICAL ONCOLOGY (2013)
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
Enders K. O. Ng et al.
PLOS ONE (2013)
Higher expression of circulating miR-182 as a novel biomarker for breast cancer
Ping-Yu Wang et al.
ONCOLOGY LETTERS (2013)
Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort
Ashley C. Godfrey et al.
BREAST CANCER RESEARCH (2013)
Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation
Nivedita Banerjee et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients
Heidi Schwarzenbach et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Analysis of serum genome-wide microRNAs for breast cancer detection
Qian Wu et al.
CLINICA CHIMICA ACTA (2012)
Decreased serum miR-181a is a potential new tool for breast cancer screening
Li-Juan Guo et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer
F-L Zhao et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
Michael G. Schrauder et al.
PLOS ONE (2012)
Comparing the MicroRNA Spectrum between Serum and Plasma
Kai Wang et al.
PLOS ONE (2012)
Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer
Yu Sun et al.
PLOS ONE (2012)
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers
Eleni van Schooneveld et al.
BREAST CANCER RESEARCH (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Meeting-in-the-middle using metabolic profiling - a strategy for the identification of intermediate biomarkers in cohort studies
Marc Chadeau-Hyam et al.
BIOMARKERS (2011)
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Sota Asaga et al.
CLINICAL CHEMISTRY (2011)
Expression of microRNAs: potential molecular link between obesity, diabetes and cancer
A. S. Ali et al.
OBESITY REVIEWS (2011)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor
Fengjun Wang et al.
GYNECOLOGIC ONCOLOGY (2010)
Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease
Helen M. Heneghan et al.
ONCOLOGIST (2010)
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Carina Roth et al.
BREAST CANCER RESEARCH (2010)
Intra-Platform Repeatability and Inter-Platform Comparability of MicroRNA Microarray Technology
Fumiaki Sato et al.
PLOS ONE (2009)
Systematic Reviews of Diagnostic Test Accuracy
Mariska M. G. Leeflang et al.
ANNALS OF INTERNAL MEDICINE (2008)
MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation
Eniko Sonkoly et al.
SEMINARS IN CANCER BIOLOGY (2008)
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells
Lisa B. Frankel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Post-transcriptional regulation of microRNA expression
Gregor Obernosterer et al.
RNA (2006)